One of the industry's most promising PACS companies is planningto go public. Cemax-Icon of Fremont, CA, is laying the groundworkfor issuing an initial public offering in the next several months.Company officials aren't saying much about the offering, in
One of the industry's most promising PACS companies is planningto go public. Cemax-Icon of Fremont, CA, is laying the groundworkfor issuing an initial public offering in the next several months.Company officials aren't saying much about the offering, in deferenceto the "quiet period" required by the Securities andExchange Commission before IPOs. They have confirmed that a prospectusfor the offering is being developed and should be available nextmonth.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.